Lee PP - Search Results

1

A phase I trial of SD-9427 (progenipoietin) with a multipeptide vaccine for resected metastatic melanoma.

Pullarkat V, Lee PP, Scotland R, Rubio V, Groshen S, Gee C, Lau R, Snively J, Sian S, Woulfe SL, Wolfe RA, Weber JS. Pullarkat V, et al. Among authors: lee pp. Clin Cancer Res. 2003 Apr;9(4):1301-12. Clin Cancer Res. 2003. PMID: 12684398 Clinical Trial.

2

Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma.

Tagawa ST, Lee P, Snively J, Boswell W, Ounpraseuth S, Lee S, Hickingbottom B, Smith J, Johnson D, Weber JS. Tagawa ST, et al. Cancer. 2003 Jul 1;98(1):144-54. doi: 10.1002/cncr.11462. Cancer. 2003. PMID: 12833467 Free article. Clinical Trial.

3

Characterization of long-term effector-memory T-cell responses in patients with resected high-risk melanoma receiving a melanoma Peptide vaccine.

Chiong B, Wong R, Lee P, Delto J, Scotland R, Lau R, Weber J. Chiong B, et al. J Immunother. 2004 Sep-Oct;27(5):368-79. doi: 10.1097/00002371-200409000-00005. J Immunother. 2004. PMID: 15314545

4

Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma.

Sanderson K, Scotland R, Lee P, Liu D, Groshen S, Snively J, Sian S, Nichol G, Davis T, Keler T, Yellin M, Weber J. Sanderson K, et al. J Clin Oncol. 2005 Feb 1;23(4):741-50. doi: 10.1200/JCO.2005.01.128. Epub 2004 Dec 21. J Clin Oncol. 2005. PMID: 15613700

5

Granulocyte-macrophage-colony-stimulating factor added to a multipeptide vaccine for resected Stage II melanoma.

Weber J, Sondak VK, Scotland R, Phillip R, Wang F, Rubio V, Stuge TB, Groshen SG, Gee C, Jeffery GG, Sian S, Lee PP. Weber J, et al. Among authors: lee pp. Cancer. 2003 Jan 1;97(1):186-200. doi: 10.1002/cncr.11045. Cancer. 2003. PMID: 12491520 Free article. Clinical Trial.

6

Cytotoxic T lymphocyte responses against melanocytes and melanoma.

Chang GY, Kohrt HE, Stuge TB, Schwartz EJ, Weber JS, Lee PP. Chang GY, et al. Among authors: lee pp. J Transl Med. 2011 Jul 27;9:122. doi: 10.1186/1479-5876-9-122. J Transl Med. 2011. PMID: 21794122 Free PMC article.

7

Rapid assessment of recognition efficiency and functional capacity of antigen-specific T-cell responses.

Kohrt HE, Shu CT, Stuge TB, Holmes SP, Weber J, Lee PP. Kohrt HE, et al. Among authors: lee pp. J Immunother. 2005 Jul-Aug;28(4):297-305. doi: 10.1097/01.cji.0000162780.96310.e4. J Immunother. 2005. PMID: 16000947

8

Diversity and recognition efficiency of T cell responses to cancer.

Stuge TB, Holmes SP, Saharan S, Tuettenberg A, Roederer M, Weber JS, Lee PP. Stuge TB, et al. Among authors: lee pp. PLoS Med. 2004 Nov;1(2):e28. doi: 10.1371/journal.pmed.0010028. Epub 2004 Nov 30. PLoS Med. 2004. PMID: 15578105 Free PMC article. Clinical Trial.

9

Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray.

Chen DS, Soen Y, Stuge TB, Lee PP, Weber JS, Brown PO, Davis MM. Chen DS, et al. Among authors: lee pp. PLoS Med. 2005 Oct;2(10):e265. doi: 10.1371/journal.pmed.0020265. Epub 2005 Sep 20. PLoS Med. 2005. PMID: 16162034 Free PMC article. Clinical Trial.

10

Microarray analysis reveals differences in gene expression of circulating CD8(+) T cells in melanoma patients and healthy donors.

Xu T, Shu CT, Purdom E, Dang D, Ilsley D, Guo Y, Weber J, Holmes SP, Lee PP. Xu T, et al. Among authors: lee pp. Cancer Res. 2004 May 15;64(10):3661-7. doi: 10.1158/0008-5472.CAN-03-3396. Cancer Res. 2004. PMID: 15150126

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

635 results

Search Page

Filters